NCT00637390 2016-12-02A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.University of Michigan Rogel Cancer CenterPhase 1 Terminated3 enrolled
NCT00109993 2010-06-11Campath-1H + FK506 and Methylprednisolone for GVHDCase Comprehensive Cancer CenterPhase 2 Completed34 enrolled
NCT00410657 2010-05-14Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled